Pharmafile Logo

Genesis Research Group announces inaugural membership of ISPOR Corporate Partnership Program

Genesis Research Group, a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, today announces it has joined selected organizations as an inaugural member of ISPOR—The Professional Society for Health Economics and Outcomes Research’s Corporate Partnership Program. This strategic alliance with ISPOR reinforces Genesis Research Group’s commitment to advancing HEOR to inform healthcare decision-making and improve patient access to life-changing therapies.

ISPOR partner seal

As a member of ISPOR’s Corporate Partnership Program, Genesis Research Group will collaborate with ISPOR and the global HEOR community to support initiatives that advance and strengthen HEOR, in alignment with ISPOR’s Strategic Plan 2030. This includes cutting edge research, education and training, and enhancing health outcomes research through evidence-based practices throughout the wider healthcare industry.

“We are very excited to launch the new Corporate Partner Program, welcome Genesis Research Group, and invite them and other organizations to contribute to ISPOR’s vision of a world where healthcare is accessible, effective, efficient, and affordable for all,” commented Rob Abbott, CEO of ISPOR. “Organizations who become ISPOR Corporate Partners will take an active role in the Society’s mission to improve healthcare decisions and achieving this vision, while elevating their presence with key stakeholders.”

“The importance of leveraging HEOR to inform healthcare decision-making has never been greater. By supporting ISPOR and becoming an inaugural member of its Corporate Partnership Program, we are reaffirming our dedication to leveraging real-world evidence, market access, and HEOR transparently and ethically to ensure that healthcare decisions are guided by high-quality evidence,” said David W. Miller, CEO of Genesis Research Group. “We are delighted to join other industry leaders in taking an active role in shaping the future of HEOR.”

MEET GENESIS RESEARCH GROUP AT ISPOR 2025 IN MONTREAL!

Contact solutions@genesisrg.com.

This content was provided by Genesis Research Group

Company Details

 Latest Content from  Genesis Research Group 

Genesis Research Group ISPOR Europe presentation ‘Planning with Insights: Even the Best Economic Models Need Validation’ features in scientific publication

We are pleased to share that The Evidence Base have carried out a 'deep dive' into a Genesis Research Group presentation on economic modeling in healthcare and harnessing stakeholder insights...

Genesis Research Group’s ISPOR Europe award-winning poster authors interviewed online

Genesis Research Group's poster 'Payer Perspective on the Impact of Real-world Evidence in Health Technology Assessments of Precision Oncology Treatments Across Europe: Results From an Online Survey' was recently named as...

Innovating Differently: A Conversation with David W. Miller, CEO of Genesis Research Group

A recent interview with Dr. David W. Miller, Chairman and CEO of Genesis Research Group, about his vision for the business, the changing face of research, and their unique value proposition...

Genesis Research Group unveils enhanced US market access data analytics

Genesis Research Group (“Genesis”), a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the expansion of its real-world data analytics capabilities...

Assessing opportunities for manufacturers to communicate the value of therapies to oncology clinical pathway (OCP) developers

Based on insights from 15 U.S. payers and providers, this white paper explores how manufacturers can effectively engage oncology clinical pathway (OCP) developers.

Genesis Research Group Announces Participation of CEO David W. Miller in New ITN Business Healthcare Program

Genesis Research Group, led by newly appointed CEO, David W. Miller, is spotlighted in June’s launch of ITN Business’ “Advancing Healthcare” program for its ‘innovate differently’ approach to supporting life...

Alice Beer of ITN Business recently interviewed David W. Miller, CEO of Genesis Research Group, on ‘Advancing Healthcare’

ITN Business invited Genesis Research Group to contribute to a news style programme 'Advancing Healthcare' featuring key opinion leaders in the healthcare sector. Our CEO David W. Miller was one...

How does Genesis Research Group ‘Innovate differently’?

New Genesis Research Group CEO David W. Miller explains what we mean when we say we help our life science clients to 'Innovate differently' and transform the way they engage...

Envision Analogue – An Introduction

Powered by primary payer market research, Envision is an online platform that provides forward-looking evaluations and comprehensive strategic direction for market access viability after an oncology product has received positive...

World EPA Congress 2024: ‘Shining the light on vaccine market access’ by Genesis Research Group

A presentation with Katrin Nather, PhD, Associate Director, and Tijana Ignjatovic, Executive Director, Genesis Research Group. Contact solutions@genesisrg.com or visit www.genesisrg.com. With more and more innovative vaccines and immunization strategies...